LCE 125 Pill - red oval, 14mm
Generic Name: carbidopa/entacapone/levodopa
Pill with imprint LCE 125 is Red, Oval and has been identified as Stalevo 125 31.25 mg / 200 mg / 125 mg. It is supplied by Novartis Pharmaceuticals.
Stalevo 125 is used in the treatment of Parkinson's Disease and belongs to the drug class dopaminergic antiparkinsonism agents. Risk cannot be ruled out during pregnancy. Stalevo 125 31.25 mg / 200 mg / 125 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for LCE 125
Stalevo 125
- Generic Name
- carbidopa/entacapone/levodopa
- Imprint
- LCE 125
- Strength
- 31.25 mg / 200 mg / 125 mg
- Color
- Red
- Size
- 14.00 mm
- Shape
- Oval
- Availability
- Prescription only
- Drug Class
- Dopaminergic antiparkinsonism agents
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Novartis Pharmaceuticals
- Inactive Ingredients
-
corn starch,
croscarmellose sodium,
glycerin,
magnesium stearate,
mannitol,
polysorbate 80,
sucrose,
ferric oxide red,
titanium dioxide
Note: Inactive ingredients may vary.
Labelers / Repackagers
| NDC Code | Labeler / Repackager |
|---|---|
| 00078-0545 (Discontinued) | Novartis Pharmaceuticals Corporation |
| 00781-5641 | Sandoz Inc. |
Related images for "LCE 125"
More about Stalevo 125 (carbidopa / entacapone / levodopa)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Drug images
- Latest FDA alerts (4)
- Side effects
- Dosage information
- During pregnancy
- Generic availability
- Drug class: dopaminergic antiparkinsonism agents
- En español
Patient resources
Professional resources
Other formulations
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
